Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Genes and Immunity

• Publication date

  2014-10-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/gene.2014.59PMID 25354579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions

  2014cited by this paper
• Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: From Molecular Bases to Practical Considerations

  2014cited by this paper
• Perforin gene mutations in 77 Chinese patients with lymphomas.

  2013cited by this paper
• Immunity and inflammation in neurodegenerative diseases.

  2013cited by this paper
• Perforinopathy: A Spectrum of Human Immune Disease Caused by Defective Perforin Delivery or Function

  2013cited by this paper
• Perforin gene mutations in 77 Chinese patients with lymphomas

  2013cited by this paper
• Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation

  2013cited by this paper
• The role of T cell apoptosis in nervous system autoimmunity.

  2012cited by this paper
• Fas‐mediated T‐cell apoptosis in chronic inflammatory demyelinating polyneuropathy

  2011cited by this paper
• Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition

  2010cited by this paper
• European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision

  2010cited by this paper
• Perforin: structure, function, and role in human immunopathology

  2010cited by this paper
• European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision

  2010cited by this paper
• Defective Fas‐mediated T‐cell apoptosis predicts acute onset CIDP

  2009cited by this paper
• Variations of the Perforin Gene in Patients With Type 1 Diabetes

  2008cited by this paper
• Variations of the perforin gene in patients with multiple sclerosis

  2008cited by this paper
• Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function.

  2007cited by this paper
• Perforin gene mutations in patients with acquired aplastic anemia.

  2006cited by this paper
• Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients’ own clinical judgement in immune-mediated polyneuropathies

  2006cited by this paper
• Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy

  2006cited by this paper
• Perforin-mediated target-cell death and immune homeostasis

  2006cited by this paper
• Fas‐mediated T‐cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy

  2006cited by this paper
• Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.

  2006cited by this paper
• Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis.

  2005cited by this paper
• A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis.

  2005cited by this paper
• Perforin and lymphohistiocytic proliferative disorders

  2005cited by this paper
• Calcium-dependent Plasma Membrane Binding and Cell Lysis by Perforin Are Mediated through Its C2 Domain

  2005cited by this paper
• A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.

  2005cited by this paper
• T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis.

  2003cited by this paper
• Role of inherited defects decreasing Fas function in autoimmunity.

  2003cited by this paper
• T‐cell cytotoxicity of human Schwann cells: TNFα promotes fasL‐mediated apoptosis and IFNγ perforin‐mediated lysis

  2003cited by this paper
• Stop codons affect 5′ splice site selection by surveillance of splicing

  2002cited by this paper
• Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases.

  2001cited by this paper
• Defective T cell Fas function in patients with multiple sclerosis

  2000cited by this paper
• Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome

  1998cited by this paper
• T-cell apoptosis in autoimmune diseases: termination of inf lammation in the nervous system and other sites with specialized immune-defense mechanisms

  1997cited by this paper
• The structure and function of proteins involved in mammalian pre-mRNA splicing.

  1996cited by this paper
• In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat

  1996cited by this paper
• Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity.

  1995cited by this paper
• Perforin: structure, function, and regulation.

  1992cited by this paper
• Structure and function of human perforin

  1988cited by this paper

• Integrated Transcriptomic and Metabolomic Analyses Reveal Physiological and Hepatic Metabolic Responses of Largemouth Bass (Micropterus salmoides) to Subacute Saline–Alkaline Stress

  2025cites this paper
• PRF1 as a prognostic gene for lymphatic metastasis in skin melanoma.

  2024cites this paper
• Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy.

  2024cites this paper
• Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations

  2022cites this paper
• Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy

  2021influential citation
• Cytotoxic Immunity in Peripheral Nerve Injury and Pain

  2020cites this paper
• Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.

  2018cites this paper
• Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia

  2017influential citation
• Human perforin gene variation is geographically distributed

  2017cites this paper
• Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation.

  2017cites this paper
• Cellular and molecular mechanisms of immune dysregulation and autoimmunity.

  2016cites this paper
• What is new in 2015 in dysimmune neuropathies?

  2016cites this paper
• Case Report: Chronic in fl ammatory demyelinating polyradiculoneuropathy rather than hemophagocytic lymphohistiocytosis — the initial phenotype of PRF1 gene mutation

  year unknowninfluential citation